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The function of dorsomedial hypothalamic neuropeptide Y (NPY) in energy balance has largely been
restricted to lactation-induced hyperphagia. In this issue, Chao et al. (2011) expand this role to include inhi-
bition of both brown fat thermogenesis and conversion of white-to-brown adipocytes in a white fat depot,
resulting in reduced energy expenditure.The study of the role of the dorsomedial
hypothalamus (DMH) in energy balance
in rodents began in 1963 by Lee Bernardis
and associates, who found that large elec-
trolytic lesions in areas of the DMH in
young laboratory rats resulted in stunted
growth and decreased eating anddrinking
(Bernardis et al., 1963). Interestingly,more
refined lesions selectively destroying only
the DMH showed these same effects,
along with normal body composition
(Bellinger and Bernardis, 2002). This
prompted extensive studies aimed at
understanding the mechanistic underpin-
nings of these changes (for historical
review of DMH lesions see Bellinger and
Bernardis [2002]). More recently, the
DMH has been heavily implicated in BAT
thermogenesis and energy expenditure
(for review see Dimicco and Zaretsky,
2007). One of the neurochemicals present
in theDMN is neuropeptide Y (NPY). Over-
expression of NPY in the DMH via an AA
resulted in enhanced food intake, body
weight, and exaggerated diet-induced
obesity in normal weight rats (Yang et al.,
2009). Chao et al. (2011) used a re-
combinant vector of AAV-mediated RNAi
targetingNPY to test themetabolic conse-
quences of the selective knockdown (KD)
of DMH NPY in rats.
This KDwas effective (50%DMHNPY
2–4 weeks after injection), specific
(arcuate unaffected), and long lasting
(16 weeks, but then 35% decrease).
There was a small decrease in body
weight of DMH NPY KD rats versus
controls when fed regular chow (20%
for the first 5 weeks); a similar effect was
found with a HFD, but KD rats exhibited
a less pronounced and shorter duration
of HFD-induced hyperphagia. In addition,
DMH NPY KD improved glucose homeo-stasis and insulin sensitivity and reduced
HFD-induced increases in blood glucose
and insulin. The authors did not determine
a mechanism for these later changes, but
they could be due to an effect of reduced
DMH NPY on pancreatic/liver function or
perhaps were secondary to increased
energy expenditure resulting in decreased
body fat, thereby improving insulin sensi-
tivity and reducing blood glucose.
Most interesting and perhaps most
important was their observation that only
the inguinal white adipose tissue (IWAT)
of DMH NPY KD rats displayed a brown
adipocyte phenotype—the so-called
‘‘brite’’ or ‘‘beige’’ cells. IWAT was visibly
brown with sizable islands of multilocular
cells that were immunoreactive for the es-
tablished brown adipocytemarker uncou-
pling protein-1 (UCP-1), the mitochondrial
protein responsible for heat generation.
Both western blot and RT-PCR showed
increased IWAT and interscapular BAT
UCP-1 protein and mRNA, supporting
the histological evidence. IWAT in KD
rats also expressed increased peroxi-
some proliferator-activated receptor
gamma coactivator 1-a mRNA, which is
associated with mitochondrial biogen-
esis, enhanced BAT thermogenic
programming, and white-to-brown trans-
differentiation of adipocytes (Barbatelli
et al., 2010). Finally, there also was an
increase in IWAT carnitine palmitoyltrans-
ferase Ia mRNA, suggestive of a transition
to lipid oxidation rather than storage
(Chao et al., 2011).
Chronic WAT sympathetic nervous
system (SNS) activation triggered by
long-term cold exposure or b3-adrenergic
receptor agonist treatment (Barbatelli
et al., 2010) induces brown adipocyte
formation in WAT (Cousin et al., 1992).Cell MetabolisThe present study also suggests that the
presence of brite/beige cells in IWAT of
DMH NPY KD rats was mediated by
SNS innervation of this tissue. Specifi-
cally, injecting the noradrenergic toxin,
6-hydroxy-dopamine unilaterally in IWAT
to achieve a local, selective, and chemical
sympathetic WAT denervation (Rooks
et al., 2005) resulted in an effective/selec-
tive IWAT sympathectomy accompanied
by a blocked or attenuated ability to
develop a brown fat phenotype relative
to the contralateral, neurologically intact
IWAT pad. This suggests that DMH NPY
might normally curb the remodeling of
IWAT to a BAT-like phenotype. The brown
adipocytes could have arisen from
myoblasts that express a ‘‘molecular
switch’’ (PRDM16 and C/EBP-b) (Kaji-
mura et al., 2009), the presence of which
turns them ‘‘brown’’; another possibility
is transdifferentiation of white-to-brown
adipocytes via chronic stimulation of
b3-adrenoceptors (Barbatelli et al.,
2010). The authors discount this latter
possibility because histologically interme-
diate stages of transdifferentiation, the
so-called paucilocular adipocytes, were
not observed. Their absence, however,
does not necessarily discount transdiffer-
entiation because the change may
already have occurred during this pro-
longed (16 week) treatment. A time-
course study should resolve this issue.
We demonstrated the CNS origins of
the SNS outflow from the brain to WAT
using the transneuronal viral tract tracer,
pseudorabies virus (PRV) (Bamshad
et al., 1998). In that study, injection of
this retrogradely traveling trans-synaptic
tract tracer resulted in more PRV-labeled
cells in the DMH after IWAT than after
epididymal WAT (EWAT) injectionm 13, May 4, 2011 ª2011 Elsevier Inc. 493
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above findings, Chao et al. (2011) consid-
ered a potential neuroanatomical basis
for the selectivity of DMH manipulation
that hinged on the apparent preferential
DMH SNS outflow to IWAT versus
EWAT. By contrast, because differential
SNS drive among WAT depots seems to
be the norm rather than the exception
(for review see Bartness et al., 2010),
perhaps there is greater SNS drive to
IWAT (and IBAT) than other WAT pads,
thereby promoting the white-to-brown
transdifferentiation.
DMH NPY KD produced several indica-
tions that the observed histological,
genetic, and protein surrogates of in-
creased thermogenesis reflect energeti-
cally relevant behavioral and physiolog-
ical consequences. These rats displayed
exaggerated nocturnal locomotor activity
and increased energy expenditure (indi-
rect calorimetry) but normal body temper-
ature; the latter is not surprising because
it is controlled by multiple redundant
regulatory mechanisms. DMH NPY KD
rats did, however, exhibit a greater
increase in body temperature during
acute cold exposure than controls.
Collectively, the data of Chao et al.
(2011) suggest that decreased DMH
NPY affects a suite of factors impinging494 Cell Metabolism 13, May 4, 2011 ª2011on energy balance including increased
energy expenditure perhaps via
enhanced BAT and WAT (brite/beige
adipocytes), improved glucose toler-
ance/insulin sensitivity, and blocked
HFD-induced increases in circulating
glucose and insulin. The selective nature
of the increase in IWAT brite/beige adipo-
cytes via SNS innervation is likely due to
chronic increases in SNS drive, thereby
activating b3-adrenoceptors and trig-
gering transdifferentiation of white-to-
brown adipocytes, and/or possibly
increases in these cells from myoblast
precursors. Whether naturally occurring
decreases in DMH NPY can unmask
WAT brownness or whether, in some
sense, this is a genetic trick, is not known.
The key to determining this is to establish
which environmental/physiological condi-
tions promote such changes. If this can
occur naturally, then decreased DMH
NPY may protect some animals from
increased adiposity and/or it could be
somehow exploited pharmacologically to
help reverse obesity.ACKNOWLEDGMENTS
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